Articles tagged with Positron Emission Tomography
A meta-analysis found that PET imaging failed to identify 50% of occult lesions in clinically node-negative patients, while incorrectly identifying normal tissue as cancerous 13% of the time. The study suggests that FDG-PET may not improve diagnostic accuracy for early head and neck cancer
Researchers at Michigan State University have developed a method to create specific rare isotopes for scientific research, opening doors to new technologies. This capability promises to advance fields like biomedicine, international security, and nuclear energy.
Researchers used PET and SPECT imaging to monitor the effectiveness of a new therapy, which successfully preserved healthy heart tissue and corrected blood flow imbalance. Nearly 50% of repaired artery segments showed normalization of glucose metabolism and coronary blood flow.
A team of Stanford University School of Medicine researchers has developed a new type of imaging system using Raman spectroscopy to illuminate tumors in living subjects. The technique allows for the detection of multiple molecular targets simultaneously, enabling finer biochemical details and more precise imaging.
Recent data from the National Oncologic PET Registry (NOPR) shows that PET scans can dramatically change treatment plans for cancer patients, with a 36.5% change in treatment or no-treatment decisions reported.
Researchers confirm that Pittsburgh Compound-B binds to beta-amyloid deposits found in Alzheimer's brains, enabling definitive diagnosis. The finding aids in early detection and treatment of the disease.
The University of Pittsburgh Center for Vaccine Research has received a $11.4 million grant to study tuberculosis using new imaging technologies. The goal is to develop more effective treatments that can be tailored to individual patients, potentially improving survival rates and curtailing the global TB epidemic.
Researchers at the University of Southern California found that combined positron emission tomography (PET) and computed tomography (CT) imaging yields greater accuracy when evaluating response to radiation therapy. This method helps identify complete responders and reduces the need for unnecessary chemotherapy treatments.
The combined scanner uses a new technology to eliminate interference between MRI and PET systems, enabling simultaneous acquisition of structural and functional information. This innovation allows researchers to correlate tumor structure with functional information, providing deeper insights into cancer research.
Researchers used PET imaging with fluorodeoxyglucose (FDG) to classify different types of dementia, achieving over 94% accuracy. The study suggests that early diagnosis using FDG-PET may improve prognosis for patients with mild cognitive impairment and other forms of dementia.
Researchers demonstrate increased endorphin release in athletes' brains during long-distance running, linked to reduced pain perception and improved mood. The study provides direct evidence for the 'endorphin hypothesis', a theory that had been disputed until now.
The American Association of Physicists in Medicine celebrates its 50th anniversary, highlighting key contributions of medical physicists to medicine. Medical physicists have developed technologies such as MRI, CT scanning, and PET scanning, which have transformed imaging and cancer treatment.
Researchers found that early brain activity is shaped by language experience and plays a crucial role in speech perception. The study reveals that melody of speech engages multiple brain areas, including both hemispheres, and interacts with general sensory-motor processes.
A multi-institutional study found PET more reliable than CT in characterizing lung nodules as malignant. PET's superior specificity led to correctly classifying 58% of benign nodules misclassified on CT.
A UCLA study found PET scanning more sensitive and accurate than conventional imaging methods in detecting treatment response in sarcoma patients. Standard size-based evaluation methods only identified 20% of responders, while PET accurately picked up all responders.
The PEM/PET system can spot tumors half the size of standard imaging systems, and complete an image and biopsy in a similar time frame. It features high-resolution PET images of the breast, guiding needle biopsies with a robot arm.
Researchers discovered significant changes in brain activity with intensive cognitive-behavioral therapy, leading to improved symptoms and reduced anxiety. The study suggests that this type of therapy may be more effective than previously thought, with potential implications for treatment.
A recent study published in the Journal of Nuclear Medicine found that PET/CT imaging significantly outperforms conventional imaging for detecting malignant tumors in children. The imaging modality provides additional information about cancer in children, potentially sparing them from overtreatment.
Researchers used PET imaging and bioluminescence to track stem cell behavior in small animal models, determining their fate and potential applications in treating heart diseases, brain disorders, and cancer. The unique combination of these imaging techniques offers a reliable method for labeling stem cells.
PET imaging enhances lung cancer staging by providing complementary information on biochemical processes, accurately differentiating between benign and malignant tumors as small as 1 centimeter. The study also found PET to be more effective for mediastinal staging in non-small cell lung cancer.
A systematic review of recent studies suggests PET imaging can accurately diagnose and stage lung cancer, even in early stages. The imaging modality is found to be more accurate than CT imaging for treatment decisions in non–small-cell lung cancer patients.
Post-treatment PET scans can accurately detect cervical cancer tumor response and predict long-term survival. The scans help identify patients whose tumors have not responded to therapy, allowing for alternative treatment options.
A comprehensive review by the UK National Health Service found that PET scans can help diagnose and treat certain types of cancer more accurately than other imaging technologies. However, it is unclear whether these advances lead to improved patient outcomes and survival rates.
A PET scan significantly improves the accuracy of diagnosing Alzheimer's disease and frontotemporal dementia (FTD) by measuring brain sugar uptake. The study found that FDG-PET scans correctly diagnosed FTD and Alzheimer's in almost 90% of cases, increasing accuracy by 14%.
Researchers found that quantitative index adds accurate information about patients' responses to first-line chemotherapy, improving tumor response prediction. This method can also identify disease transformation and shorten treatment for favorable responders.
Researchers aim to improve breast cancer screening by developing new anatomical imaging methods, including MRI and PET, and sensitive histopathologic detection techniques. The goal is to identify precancerous lesions and map their extent for precise surgery.
A new study found that people's responses to placebo treatments are linked to their brain's dopamine activity, particularly in the nucleus accumbens. The study used two types of brain scans to investigate this phenomenon and suggests that individual expectations play a significant role in determining the effectiveness of placebos.
Researchers found a strong correlation between tumor responses during treatment and three months after completion, suggesting PET scans can be performed earlier to modify treatment plans. This could lead to better tumor control and survival rates, potentially changing standard practice guidelines.
A UT study found that cardiac PET-CT scanners incorrectly indicate coronary artery disease in up to 40% of patients due to software flaws. The researchers developed a solution to address the issue, resulting in accurate images of blood flow in the heart.
Researchers from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) report promising early findings on imaging and biomarker analysis. The study reveals improved methods and uniform standards for tracking brain changes and predicting Alzheimer's disease, potentially leading to faster and more efficient evaluation of potential thera...
Researchers from University of Pennsylvania and Philips team demonstrate improved image quality and shorter patient scan times with advanced molecular imaging technology. The study, released at SNM's 54th Annual Meeting, shows that TOF/PET imaging can achieve better quality images in less time, benefiting patients and doctors.
Researchers developed a 3D fusion technique combining CT angiography and nuclear imaging scans to improve the accuracy of diagnosing coronary artery disease. This technology significantly enhances diagnosis and could be used in the future with molecular imaging agents to detect and guide treatment.
Researchers unveiled the world's first simultaneous PET/MR images of the human brain, offering unprecedented imaging capabilities for neurological studies. The technology has the potential to revolutionize the assessment of Alzheimer's, Parkinson's, epilepsy, depression, and schizophrenia.
Beta-amyloid accumulation is linked to brain dysfunction even in normal elderly individuals, according to a study. Researchers used PIB PET scans to detect early pathological changes of Alzheimer's disease and demonstrated its potential for identifying those in need of treatment.
A study published at SNM's 54th Annual Meeting found that PET/CT imaging detected more sites of disease and identified women whose disease was likely to progress. The technique influenced treatment decisions in 59% of women with recurrent ovarian cancer, improving management outcomes.
Researchers developed a novel imaging technique combining CT and PET scans to detect 'high-risk' plaque that causes heart attacks and strokes. The approach provides detailed information about the size of plaque, inflammation, and potential risks, offering new insights into atherosclerosis.
Using metabolic imaging, UCLA researchers found that FLT-PET is a powerful predictor of treatment response and outcome in brain tumor patients. The study showed that FLT-PET imaging was predictive of patients' overall survival, with those who responded to drug treatment living three times as long as those who did not.
Early metabolic imaging with PET accurately identifies patients responding to chemotherapy for esophageal cancer, noting a remarkably favorable outcome for metabolic responders. This study supports the use of PET-response-guided treatment to tailor multimodality therapy based on tumor biology.
R. Edward Coleman received the award for his contributions to molecular imaging and nuclear medicine practice, particularly in advancing positron emission tomography (PET) for breast cancer, Alzheimer's, and brain tumors. His research has had a significant impact on medicine, and he is recognized as one of the best doctors in America.
Adding radioimmunotherapy to chemotherapy increased complete response rates for patients with follicular lymphoma, a slow-growing type of non-Hodgkin's lymphoma. Over 90% of study patients responded completely to the treatment, with limited side effects.
Researchers are developing new electronics to accurately measure subatomic particles, potentially detecting cancer at an earlier stage. Improved Positron Emission Tomography (PET) technology could lead to better diagnoses and more accurate tumor detection.
Researchers found that FDG-PET imaging can identify patients who respond to chemotherapy, allowing for early termination of futile treatment. This improves patient care by providing an alternative approach, such as stopping chemotherapy or switching to a more adequate therapeutic option.
A study by University of Manchester researchers reveals that arthritis pain activates the brain's emotional and fear centers, processing emotions and aversive conditioning. The findings suggest a more intense emotional response to arthritic pain compared to experimental pain.
A study published in Arthritis & Rheumatism found that arthritis pain is processed in brain areas associated with emotions and fear. The medial pain system, including the cingulate cortex and amygdala, was activated during arthritic pain, suggesting a stronger emotional impact than experimental pain.
Researchers have identified promising new drug combinations that can improve survival rates among patients with severe heart disease. Studies show that using imaging technologies like PET-guided therapy can also help doctors make more accurate decisions about therapies for these high-risk patients.
A new study reports that zolpidem, an insomnia drug, temporarily improved brain function in a patient with akinetic mutism. The patient was able to communicate and perform basic functions after receiving the drug for insomnia. PET scans revealed increased brain activity in areas involved in motivation and cognitive processing.
A team led by Massachusetts General Hospital confirms that Pittsburgh Compound B binds to amyloid-beta protein in the human brain, a key step in Alzheimer's disease diagnosis. The findings support using PET imaging with PiB to track treatment results and emphasize the need for clinical symptom evaluation.
A new study at Memorial Sloan Kettering Cancer Center demonstrates the effectiveness of PET imaging in identifying clear cell renal carcinoma, a highly aggressive type of kidney cancer. The technique has a sensitivity of 94% and specificity of 100%, making it a valuable tool for determining whether surgery is needed.
International team develops standardized guidelines for assessing lymphoma treatment response, incorporating new imaging technologies. The revised guidelines aim to improve therapies and facilitate the development of new treatments.
Researchers used positron-emission tomography (PET scan) to diagnose a type of congenital hyperinsulinism, achieving an accuracy rate of 96% in locating the abnormal spot. The technology is highly effective in pinpointing focal lesions, guiding surgeons to curative organ-sparing surgery.
The International Harmonization Project has developed new guidelines for assessing lymphoma treatment, providing uniform criteria for clinical trials and interpreting response to treatment. The revised guidelines incorporate PET scans and immunohistochemistry, allowing for more accurate assessment of tumor viability.
The supplement examines the role of 18F-FDG PET/CT imaging in cancer diagnosis, treatment planning, and monitoring. It provides guidelines and algorithms for the use of PET/CT in evaluating and managing head and neck cancer and thyroid cancer.
Researchers have developed a promising radiotracer, FACBC, to improve prostate cancer diagnosis and staging. The tracer shows high accumulation in cancer cells and potential for overcoming traditional PET tracers' drawbacks.
Researchers developed a new imaging technique that detects abnormal brain protein deposits associated with Alzheimer's disease in mild cognitive impairment. The study found that the method was more effective in differentiating patients with Alzheimer's disease from normal subjects, and tracked disease progression over a two-year period.
A new imaging molecule, FDDNP, can detect and map plaques and tangles in the brains of people with Alzheimer's disease, enabling earlier diagnosis and potentially preventing progression. The compound binds to abnormal deposits on PET scans, correlating well with clinical diagnoses measured by memory tests.
Researchers found whole-body PET/CT scans accurate in diagnosing colorectal cancer stages, changing patient management in 9% of cases. This non-invasive method offers a single-stage approach, reducing burden on patients and clinicians compared to conventional imaging procedures.
A new study published in the Journal of Nuclear Medicine found that young smokers who quit smoking can normalize abnormal coronary artery function within a month. The PET imaging study examined the effects of smoking cessation on coronary endothelial dysfunction in healthy young male adults.
Advances in PET technology enable early disease detection and personalized medicine, potentially leading to annual screenings for common diseases. Doctors will use PET's molecular imaging ability to visualize precise molecular changes, informing treatment and prevention strategies.
A study of 79 patients diagnosed with obsessive-compulsive disorder (OCD) and compulsive hoarding syndrome found that serotonin reuptake inhibitor (SRI) medication, paroxetine, significantly improved symptoms. Compulsive hoarding is a psychiatric disorder characterized by failure to discard objects due to anxiety and excessive clutter.
Scientists create radioactively tagged molecules for positron emission tomography (PET) scans, providing insights into addiction and brain function. The radiotracers help monitor drug distribution and receptor activity in the brain, revealing key factors in addiction.